Skip to content
Life sciences consumables, equipment and services, delivered across Saudi Arabia.
Rat Monoamine Oxidase A (MAOA) ELISA Kit
  • Rat Monoamine Oxidase A (MAOA) ELISA Kit
Assay Genie

Rat Monoamine Oxidase A (MAOA) ELISA Kit

Price on request

SKUPriceQuantity
RTDL00648

Price on request

Description

This description has not been verified against the manufacturer's datasheet. Check the datasheet before you order, or ask us to confirm a specification. Ask us to confirm

Monoamine oxidase A (MAOA) is a mitochondrial flavoenzyme central to the catabolism of serotonin, norepinephrine, and dopamine, and quantitative measurement of this enzyme in rat specimens is a frequent requirement in neuroscience and behavioral pharmacology research. The Assay Genie Rat Monoamine Oxidase A (MAOA) ELISA Kit is configured as an immunoassay for research use only and is provided in a 96-assay microplate format that supports batched sample analysis.

Reactive with rat specimens, the kit accepts serum or plasma, along with tissue homogenate preparations, accommodating experimental designs that span peripheral biomarkers and central nervous system regions such as the brainstem, prefrontal cortex, and hypothalamus where MAOA expression is documented. Each kit ships with the principal reagents required for the immunoassay workflow, including a pre-coated plate, calibration standards, detection antibody, wash buffer, substrate, and stop solution, presented in individually labeled vials for organized bench setup.

Typical research applications include investigation of antidepressant pharmacology, modulation of serotonergic tone, anxiety-like behavior paradigms, and studies of MAOA gene-environment interactions in translational rat models. Reagents should be refrigerated between uses to preserve enzymatic reactivity and antibody performance, and calibration standards are recommended to be prepared fresh for each analytical run.

The immunoassay format enables laboratories to generate quantitative MAOA concentration data across treatment cohorts, genetic backgrounds, or pharmacological interventions, providing a foundation for downstream statistical comparison of monoaminergic enzyme expression in rat experimental systems.